PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,023.50
Bid: 1,024.50
Ask: 1,025.00
Change: -1.50 (-0.15%)
Spread: 0.50 (0.049%)
Open: 1,023.50
High: 1,027.50
Low: 1,019.50
Prev. Close: 1,025.00
SN. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

9 Mar 2022 18:15

RNS Number : 2637E
Smith & Nephew Plc
09 March 2022
 

9 March 2022

Smith & Nephew plc

Transaction in Own Shares

Smith & Nephew plc (the "Company") announces today it has purchased the following number of its own ordinary shares of US 20¢ each through Merrill Lynch International, as part of its USD $125 million share buyback programme announced on 22 February 2022 and in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 14 April 2021.

 

Aggregated details of share purchase transactions according to trading venue are set out below:

 

Date of transaction:

Venue:

Number of ordinary shares repurchased:

Highest price paid per ordinary share (GBP):

Lowest price paid per ordinary share (GBP):

Volume weighted average price paid per ordinary share (GBP):

09/03/2022

XLON

61,000

£12.2150

£11.9250

£12.1099

09/03/2022

BATE

0

£0.00

£0.00

£0.00

09/03/2022

CHIX

0

£0.00

£0.00

£0.00

 

The Company intends to hold these shares in Treasury and then cancel them.

Since 23 February 2022, the Company has purchased 2,404,778 shares at a cost (including dealing and associated costs) of £29,720,424.65.

 

Following the purchase of these shares, the Company holds 7,694,002 of its shares in Treasury. The Company's issued share capital, with one voting right per share consists of 877,523,757 ordinary shares of US20¢ each (excluding treasury shares). This figure of 877,523,757 is the figure which should be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

These purchases were made by Merrill Lynch International on behalf of the Company.

This announcement is made in accordance with the requirements of LR 12.4.6.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), a full breakdown of the individual purchases is attached to this announcement.http://www.rns-pdf.londonstockexchange.com/rns/2637E_1-2022-3-9.pdf

 

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

 

Tel: 01923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSSIFAUEESESD
Date   Source Headline
1st Apr 201911:27 amRNSTotal Voting Rights
1st Apr 20199:00 amRNSAcquisition of Leaf Healthcare, Inc.
25th Mar 20199:00 amRNSRe-presented Historical Quarterly Revenue Analysis
13th Mar 20197:00 amRNSMulti-asset digital surgery and robotic ecosystem
12th Mar 20191:00 pmRNSSmith & Nephew to acquire Osiris Therapeutics, Inc
8th Mar 20191:31 pmRNSDirector/PDMR Shareholding
8th Mar 20191:29 pmRNSDirector/PDMR Shareholding
8th Mar 20191:27 pmRNSDirector/PDMR Shareholding
4th Mar 20194:08 pmRNSAnnual Financial Report
4th Mar 20193:42 pmRNSAnnual Financial Report
1st Mar 201911:43 amRNSTotal Voting Rights
19th Feb 20193:08 pmRNSTransaction in Own Shares
15th Feb 20195:32 pmRNSTransaction in Own Shares
14th Feb 20195:37 pmRNSTransaction in Own Shares
14th Feb 20198:14 amRNSDirector Declaration
13th Feb 20195:17 pmRNSTransaction in Own Shares
12th Feb 20195:20 pmRNSTransaction in Own Shares
11th Feb 20195:41 pmRNSTransaction in Own Shares
8th Feb 20191:59 pmRNSTransaction in Own Shares
8th Feb 20199:20 amRNSDirector/PDMR Shareholding
8th Feb 20199:17 amRNSDirectorate Change
7th Feb 20197:00 amRNSFinal Results
1st Feb 20192:04 pmRNSBlock listing Interim Review
1st Feb 201912:06 pmRNSTotal Voting Rights
22nd Jan 20192:38 pmRNSSmith & Nephew acquires Ceterix Orthopaedics
16th Jan 20195:19 pmRNSDirector/PDMR Shareholding
11th Jan 20199:00 amRNSNotice of Results
7th Jan 20197:00 amRNSSmith & Nephew to present today at JP Morgan
4th Jan 20195:32 pmRNSSmith & Nephew at JP Morgan Healthcare Conference
2nd Jan 201911:19 amRNSTotal Voting Rights
18th Dec 20184:30 pmRNSAcquisition
7th Dec 201810:26 amRNSDirector/PDMR Shareholding
4th Dec 20184:20 pmRNSDirector/PDMR Shareholding
4th Dec 20184:18 pmRNSDirector/PDMR Shareholding
3rd Dec 201812:00 pmRNSTotal Voting Rights
26th Nov 20183:07 pmRNSTransaction in Own Shares
22nd Nov 201811:57 amRNSTransaction in Own Shares
21st Nov 20185:31 pmRNSTransaction in Own Shares
20th Nov 20185:18 pmRNSTransaction in Own Shares
19th Nov 20185:49 pmRNSTransaction in Own Shares
16th Nov 20182:19 pmRNSDirector/PDMR Shareholding
16th Nov 201810:21 amRNSDirector/PDMR Shareholding
16th Nov 20188:59 amRNSTransaction in Own Shares
14th Nov 20184:46 pmRNSDirector/PDMR Shareholding
12th Nov 20183:46 pmRNSDirector/PDMR Shareholding
9th Nov 20184:26 pmRNSDirector/PDMR Shareholding
6th Nov 20188:55 amRNSDirector/PDMR Shareholding
5th Nov 20188:24 amRNSDirector/PDMR Shareholding
1st Nov 20184:26 pmRNSDirector/PDMR Shareholding
1st Nov 20183:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.